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Abstract: Infertility is actually widespread pathological condition, which aff ected one in every four cou-
ples in developing countries. Approximately one third of all cases are connected with tubal factor infertil-
ity, oft en accompanies by endometriosis, acute salpingitis, urogenital infections etc. Th e newly identifi ed 
telocytes (TCs) have multiple potential bio-functions and might participate in the fertility problems. 
Th ey infl uence on structural and functional integrity of oviduct tissue. Despite recent discovery, TCs 
involvement in the majority of physiological and pathological processes is still unclear and require sig-
nifi cant increasing of deep observations and data analysis. Focusing on female reproductive system help 
better understands the main reasons of infertility, while evaluation of TCs impact on Fallopian tube and 
uterus contractility might be a key point of its correction. Th e article summarizes the main features of 
telocytes in Fallopian tubes, emphasizing their involvement in pathophysiological processes and tubal 
factor infertility.
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Introduction: infertility in statistics
Infertility remains a highly prevalent condition worldwide. According to the Practice 
Committee of the American Society for Reproductive Medicine, infertility is a dis-
ease, defi ned by the failure to achieve a successful pregnancy aft er 12 months or more 
of appropriate, timed unprotected intercourse or therapeutic donor insemination [1]. 
Th ree surveys on the overall prevalence of infertility published in the new millen-
nium (2004, 2007 and 2012) have very diff erent results, between 48.5 million and 186 
million. It is estimated that it may aff ect between 8 and 12% of couples at reproduc-
tive age, with a probable global incidence average of 9% [2]. Ombelet et al. published 
that worldwide more than 70 million couples suff er from infertility and bilateral tubal 
occlusion is the most common underlying cause [3]. 
Telocytes: identifi cation and main features
Telocytes, a novel type of interstitial cell population fi rstly described by Popescu group 
in 2005 and characterized by a small cell body and extremely long prolongations named 
telopodes (Tps) with alternating thin segments (podomers) and dilated segments (po-
doms) [4]. Currently these cells are identifi ed by transmission electron microscopy 
(TEM), immunohistochemistry and immunofl uorescence. TCs are widely distributed 
in vertebrate (fi sh, reptiles, birds, mammals, including humans) [5]. TCs have been 
described to possess diff erent immunophenotype markers, such as the sialylated trans-
membrane glycoprotein CD34 and the tyrosine kinase receptor c-kit/CD117, among 
a variety of cavitary and non-cavitary organs: heart (endo-, myo-, epi- and pericardium, 
myocardial sleeves, heart valves); digestive tract and annex glands (esophagus, stomach, 
duodenum, jejunum, liver, gallbladder, salivary gland, exocrine pancreas); respiratory 
system (trachea and lungs); urinary system (kidney, renal pelvis, ureters, bladder, ure-
thra); female reproductive system (uterus, Fallopian tube, placenta, mammary gland); 
vasculature (blood vessels, thoracic duct); serous membranes (mesentery and pleura); 
other organs (skeletal muscle, meninges and choroid plexus, neuromuscular spindles, 
fascia lata, skin, eye, prostate, bone marrow) [3–8]. Th ey also have immunopositivity 
for numerous markers such as plated-derived growth factor receptor alpha and beta 
(PDGFRα and -β), VEGF, inducible nitric oxide synthase (iNOS), calveolin-1, vimentin, 
connexin 43, estrogen and progesterone receptors, CD44, desmin, nestin and cadher-
in-11 [4, 7, 9]. Important to note, that the most applicable method to identify TCs is im-
munohistochemistry combined with TEM. Despite the fact that has not yet been found 
a specifi c marker for TCs, usually for primary identifi cation scientists use CD34 [9].
Th e TC interstitial system is composed of cells that by either homocellular or 
heterocellular contacts integrates the overall information from vascular, nervous and 
immune system, interstitium and stem cells [9]. In pathological condition, these cells 
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displayed ultrastructural change, signifi cantly reduced and progressively disappeared 
[8, 10].
Fallopian tubes as a point of infertility
Fallopian tube is a central organ of human reproduction as plays an essential role in 
transport of both gametes and embryos and in early embryogenesis [11]. Th e length of 
each oviduct ranges from 15 to 20 cm, while tubal lumen can be from tenths of a mil-
limeter to several millimeters depending on the anatomical part. It is lined by simple 
cuboidal or columnar epithelium containing secretory and ciliated cells, which pro-
duce tubular fl uid and facilitate transport of gametes, respectively [12]. Ciliated cells 
are found predominantly on the apex of the mucosal folds. Th eir reactivity is aff ected 
by a variety of hormonal and neuronal stimuli. Many pathological conditions associ-
ated with infertility and ectopic pregnancies have been shown either to destroy cilia or 
to reduce ciliary motion or both. [11]. Also, Fallopian tube consists of smooth muscle 
cells (SMC), immunocompetent cells such as leukocytes, and blood vessel cells [13, 
14]. Th e fi rst description of a distinct oviductal cycle in women was made in 1928 [11].
Tubal factor infertility is the most common cause of female infertility and 
diagnosed in approximately 30% to 35% of younger and older infertile women. Th e 
main causes of tubal factor infertility are congenital bilateral agenesis and full oviduct 
blockage, infl ammation of the pelvic organs (in the majority caused by infections), 
endometriosis, former surgical treatment lead to adhesive disease, polyps and 
diverticula of Fallopian tubes, hydrosalpinx [15]. 
Th e most prevalent cause of tubal factor infertility is pelvic infl ammatory disease 
(PID) and acute salpingitis. Tubal damage from PID causes inflammation and 
long-term tubal changes, such as fi mbrial agglutination, fi mbrial phimosis, tubal 
obstruction, hydrosalpinx, and nodular thickening of the muscularis layer of the 
isthmic portion of the fallopian tube called salpingitis isthmica nodosa. Th e risk of 
ectopic pregnancy can increase sixfold to sevenfold aft er an episode of PID [14]. 
Endometriosis aff ects over 70 million women worldwide and pathophysiological is 
associated with infl ammation and elevated cytokine levels [12]. Among women with 
tubal factor infertility, endometriosis accounts for 7% to 14% [16]. Th e expression of 
progesterone receptors A and B types (PR-A and PR-B) is altered in endometriotic 
lesion stromal cells. Attia et al. showed that PR-A was reduced while PR-B was absent 
compare with eutopic endometrium [17]. Macrophage migration inhibitory factor 
(MIF) is a potent mitogenic factor for human endothelial cells in vitro and tumor 
angiogenesis in vivo. Endometriosis leads to increasing of its expression in ectopic and 
eutopic endometrium. Moreover, MIF has been shown to stimulate prostaglandin E2 
(PGE2), cyclooxygenase-2 (COX-2), vascular endothelial growth factor (VEGF), 
interleukin-8 (IL-8), and monocyte chemotactic protein-1 (MCP-1) expression. Yang 
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et  al. emphases that endometriosis-associated infertility seems to be multifactorial, 
involving mechanical, molecular, and genetic mechanisms [18, 19].
Possible role of telocytes in tubal infertility
Telocytes are oft en observed between smooth muscle bundles and make contacts with 
smooth muscle cells. Th ey are located around capillaries and make junctions with fi -
brocytes and pericytes. Urban et al. observed that TCs were localized mainly in tu-
nica muscularis externa [20]. Likewise, TCs form heterocellular synapse to mast cells 
(MCs) with their Tps and potentially participated in immunoreactions [21, 22]. Th e 
last experiments have shown that TCs also contains in the fi mbriae of Fallopian tubes 
[6, 23–26]. Although, its spatial distribution gradient decreases from the subepithelial 
area toward serosa measured in the relative numeric density (percentage of TCs out 
of all cells found in that area) (Table 1).
Table 1. Distribution of telocytes in Fallopian tube stratums.
Area of the human Fallopian tube Density of TCs (%)
Th e border epithelium/lamina propria, a ‘belt’ 10 μm thick underneath 
the basement membrane of the endosalpinx epithelium 18 ± 2
Th e subepithelial portion of lamina propria (~20 μm thick) 11.7 ± 0.9
Area, containing the whole lamina propria thickness 9
Tunica muscularis 7.8 ± 1.2
Remaining zone beneath serosa not assessed
 
As TCs make heterocellular contacts with various oviduct interstitium components, 
they might be involved in intercellular information exchange between various stromal 
cells, or represent a “functional unit” by participating in making a primitive nervous 
system through telocytes-exosomes gap junctions-cytoskeleton [18, 22]. 
Yang et al. reported that in acute salpingitis-affected oviduct tissues, TCs 
was obviously decreased or lost, severely damaged/degenerated with multiple 
ultrastructural abnormalities, such as loss of organelles, numerous swollen nucleus, 
mitochondria and rough endoplasmic reticulum dilatation, cytoplasmic vacuolization, 
discontinue or dissolution of Tps, swollen or loss of intercellular junction [21].
Endometriosis is estrogen-dependent disease and might leads to local damage 
of TCs. Massive neutrophils infi ltration and overproduced inducible nitric oxide 
synthase (iNOS), COX-2, oxidative stressor (lipid peroxide, LPO) and estradiol in 
oviduct tissue suggested mechanism of infl ammatory-induced TCs damage [21, 22]. 
On the other hand, he also proposed that TCs damage might contribute to structural 
abnormalities of oviduct [18, 22]. 
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The morphology and functional integrity of the Fallopian tube are estrogen 
dependent [13]. Biological activity of 17β-estradiol (E2) is linked to both inhibition and 
stimulation of the interactions between progesterone (P4) and progesterone receptor 
(PR) in the female reproductive tract. Oviduct TCs express estrogen/progesterone 
receptors, and thus might act as “hormonal sensors” [4, 5, 27–29]. 
Kissler et al. observed dysperistalsis of utero-tubal smooth muscle and Yang et al., 
taking into account his results, suggested a possible role of “tubal motility disorder” in 
contribution to endometriosis-associated tubal factor infertility [18, 29]. Combination 
of estrogen and progesterone is necessary for normal contractility of smooth muscle 
cells in oviduct. Adrenomedullin (ADM) is expressed in epithelial cells of the human 
and rat Fallopian tube. Th ere is evidence suggesting that circulating ADM levels 
increase and decrease along with circulating 17β-estradiol levels in humans during the 
menstrual cycle. Studies have shown that ADM increases ciliary beat frequency and 
decreases smooth muscle contractility. Estrogens impact on tubal peristalsis. Telocytes 
express both types of hormonal receptors (estrogen and progesterone) and might be 
involved in tubal contractility and dysperistalsis. Th ey form heterocellular contacts 
with smooth muscle cells and have both types of hormonal receptors. Tubal telocytes 
generates slow waves within oviduct smooth muscle and has been recognized as 
oviduct pacemaker cells [18, 22, 23].
TCs involved in organization of 3-D extracellular matrix. Th ey can regulate the 
activity of neighboring cells (stem cells, immunocytes, smooth muscle cells etc.), 
with intercellular diff erent signaling mechanisms. TCs damage and 3-D interstitial 
architectural derangement leads to abnormal tissue homeostasis and angiogenesis, 
interstitial fi brosis and consequent reproductive problems [9, 21, 30].
Secretion of epidermal growth factor and insulin-like growth factors is signifi cantly 
important for normal fertilization and embryo development, but it is changed in 
endometriosis affected tissue. Others involved in fibrosis and neo-angiogenesis. 
TCs are positive for growth factors receptors (VEGF, PDGFRα and -β). Numerous 
experiments have shown involvement of vessels in endometriosis and adenomyosis 
pathogenesis. Likewise normal microenvironment and the infl ammation disease are 
based on blood circulation in capillaries of the uterus and oviduct. Neo-angiogenesis 
is the main in pathogenesis of tubal ectopic pregnancy. TCs not only located around 
capillaries and make junctions with fi brocytes and pericytes, they also express growth 
factors receptors involved in neo-angiogenesis [9, 31–33]. 
Telocytes also surrounded stem cell niches with telopodes and heterocellular 
contacts. They may participate in oviduct tissue repair/regeneration processes. 
Damage or loss of TCs will change the activity of telocytes-stem cells and decrease 
tissue reparation or renewal capacity, subsequently inducing development of tissue 
fi brosis. As a result — oviduct dysfunction and infertility. TCs-mediated function-
specifi c intercellular signaling contributes to regulate activity of neighboring cells, 
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including involvement in neurotransmission by spreading the slow waves generated 
by the pacemaker interstitial cells of Cajal (ICCs) in the gut, modulating tissue 
development/remodeling/metabolism, immunoregulation/immunosurveillance and 
maintaining homeostasis of the gastrointestinal tube [9, 31, 34, 35]. We postulate that 
similar mechanisms concerning telocytes in fallopian tube might be involved in the 
pathological processes, leading to infertility of oviductal origin. 
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